Daily Bulletin

Men's Weekly

.

Servatus launches Australia's first human study into the effects of live biotherapeutics on insomnia

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
  • Study to look at the link between the gut microbiome and sleep, by treating patients who suffer from insomnia with live biotherapeutics
  • Phase I/II trial will run during 2022, with results expected in 2023
  • Close to 15% of the Australian population suffer from insomnia, with sleep disorders costing the economy and society around $51 billion annually

SYD...

Read more: Servatus launches Australia's first human study into the effects of live biotherapeutics on insomnia

Business News

Integrating Marketing Automation Workflows with Headless CMS: Creating a Unified Engine for Scalable Growth

Marketing automation is a necessary component of modern engagement with customers. Automated emails, triggered campaigns, lead nurturing and lifecycle messaging enable brands to scale their messagin...

Daily Bulletin - avatar Daily Bulletin

Why Split Corrugated Conduits Are Essential For Protecting Electrical And Solar Installations

Modern electrical systems require reliable protection for wiring and cables to ensure safety, durability, and long-term performance. In residential, commercial, and industrial environments, conduits a...

Daily Bulletin - avatar Daily Bulletin

Launching Global Product Campaigns with Decoupled Content Architecture

There's perhaps no more challenging project for an international enterprise to pursue than a global product launch campaign. At the same time, various regions, languages, compliance standards, digit...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business